8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Chapter 15 Chapter 16 Chapter 17 Chapter 18 Assessing intestinal permeability in Crohn’s disease patients using orally administered 52Cr-EDTA PLoS One 2019;14(2):e0211973. Serological biomarkers of type I, III, and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn’s disease Alimentary Pharmacology and Therapeutics 2022;56(4):675-693. The effect of phenotype and genotype on the plasma proteome in patients with inflammatory bowel disease Journal of Crohn’s and Colitis 2022;16(3):414-429. Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease Scientific Reports 2022;12(1):14581. Long-term dietary patterns are reflected in the plasma inflammatory proteome of patients with inflammatory bowel disease Nutrients 2022;14(12):2522. PART III: OXIDATIVE STRESS BIOMARKERS IN IBD Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease Trends in Molecular Medicine 2020;26(11):1034-1046. Serum free thiols predict cardiovascular events and all-cause mortality in the general population: a prospective cohort study BMC Medicine 2020;18(1):130. Crohn’s disease in clinical remission is marked by systemic oxidative stress Frontiers in Physiology 2019;10:499. Serum free thiols are superior to fecal calprotectin in reflecting endoscopic disease activity in inflammatory bowel disease Antioxidants 2019;8(9):351. HIF1α-dependent induction of TFRC by a combination of intestinal inflammation and systemic iron deficiency in inflammatory bowel disease Frontiers in Physiology 2022;13:889091. 293 315 363 413 453 489 491 519 547 569 595
RkJQdWJsaXNoZXIy MjY0ODMw